Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9614 posts found.

leukamia

Two infants in remission from leukaemia after CAR T-Cell therapy

January 26, 2017 Research and Development

Researchers at the Great Ormond Street Hospital have published the successful treatment of two infants suffering from leukaemia by treatment …
News
peter_wheatley_price

Takeda UK names new market access director

January 25, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda

Takeda UK has appointed Peter Wheatley Price to the role of market access director, where he will also sit on …
Appointment

MHRA accepts Roche’s Tecentriq into Early Access to Medicines scheme

January 25, 2017 Research and Development, Sales and Marketing MHRA, Roche, eams, tecentriq

Roche’s Tecentriq (atezolizumab) has scored another positive opinion, this time from the Medicines and Healthcare products Regulatory Agency (MHRA), which …
News
medication

Statins revealed to potentially aid cancer treatment

January 25, 2017 Research and Development Cancer, University of Kansan, statins

New research, conducted at the University of Kansas, has emerged that reveal a potential use for statins beyond their current …
News
shutterstock_187433765

Two-step treatment cuts off cancer’s backup defences

January 25, 2017 Research and Development Cancer, sarcoma, washington university

New research conducted at Washington University’s School of Medicine and published in Cell Reports details a new method for fighting …
News
cancer_cells

Breakthrough treatment for pancreatic cancer doubles survival rates

January 25, 2017 Research and Development CRUK, Cancer Research UK, Pancreatic cancer

Research led by Liverpool University and funded by Cancer Research UK has shown that a combination treatment of two off-patent …
News

Indian pharma firm caught shredding documents at 1am by FDA

January 24, 2017 Manufacturing and Production, Research and Development FDA, Hetero Labs, observations

Hetero Labs, an Indian pharmaceutical firm, has been observed by the FDA shredding what the FDA judged to be controlled …
News
pharmafocus_march

Pharmafocus January/February is now live!

January 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, digital edition

Inside this issue…
News
abbvie_0

EMA Accelerated Assessment for AbbVie’s hepatitis C regimen

January 24, 2017 Manufacturing and Production, Research and Development AbbVie, EMA, hepatitis C

AbbVie has announced that its investigational, pan-genotypic regimen of Glecaprevir/Pibrentasvir has been awarded Accelerated Assessment by the European Medicines Agency …
News
computer_doctor

Thinking big data

January 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, IBM Watson Health, ibm

The potential solutions offered by ‘big data’ seems to offer a vision of the future but potential solutions aren’t enough …
Feature
biopsy

“Biggest leap in decades” for prostate cancer, 1 in 4 could avoid biopsies

January 20, 2017 Medical Communications, Research and Development Biposy, prostate cancer

A new study has estimated that one in four men could avoid unnecessary invasive biopsies to detect prostate cancer – …
News

J&J’s Imbruvica scores fifth FDA lymphoma approval

January 20, 2017 Medical Communications, Research and Development, Sales and Marketing FDA, Marginal Zone Lymphoma, imbruvica

Johnson & Johnson’s Imbruvica (ibrutinib) has scored its fifth indication approval in the US for the treatment of Marginal Zone …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday, and there have been some big revelations for the pharma industry this week. Brexit, the ever-present hot topic …
News
jenny_tragner_-_main

Pharmaceutical R&D tax credit regulatory legislation: The need for clarity

January 20, 2017 Medical Communications, Research and Development, Sales and Marketing R&D, pharmafile

Since their introduction in the UK in 2000, R&D tax credits have provided a significant boost to pharmaceutical and biotech …
News

Sanofi diabetes drug Sulinqua green-lighted in Europe

January 19, 2017 Research and Development, Sales and Marketing Sanofi, Sulinqua

Sanofi’s diabetes drug Suliqua has been granted marketing authorisation by the European Commission, giving the go ahead for the launch …
News
The Gateway to Local Adoption Series

Latest content

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026